Global Naloxone Market Size Study By Product (Spray Forms, and Injectable Forms), By Application (Opioid Overdose, and Preventing Opioid Abuse, and Others), and By Regional (North America, Europe, Asia Pacific, Latin America, and Rest of the World) Forecasts, 2018-2025

August 2018 | 120 pages | ID: G3AB384D78BEN
Bizwit Research & Consulting LLP

Abstracts

Global Naloxone Market to reach USD XXX million by 2025.

Global Naloxone Market valued approximately USD XXX million in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors speculated to augment the markets rising availability of naloxone as a generic drug, and death cases from drug overdose increasing with alarmingly escalating rates. Continuous increase in prices of naloxone drug is a major constraint for the growth in market. Escalating engagement of private organizations and government in spreading cognizance regarding the availability of naloxone is a prime opportunity for growth in the market. Naloxone is a generic drug which is used to blocks or reverses the effects of opioid medication, including extreme drowsiness, slowed breathing, or loss of consciousness.

The regional analysis of Global Naloxone Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share. Furthermore, owing to countries such as China, India, and Japan, Asia Pacific region is also expected to exhibit higher growth rate / CAGR over the forecast period 2018-2025.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

• Spray Forms
• Injectable Forms

By Application:

• Opioid Overdose
• Preventing Opioid Abuse
• Others

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Mexico
• Rest of the World

Furthermore, years considered for the study are as follows:

• Historical year – 2015, 2016
• Base year – 2017
• Forecast period – 2018 to 2025

The industry is seeming to be fairly competitive. Some of the leading market players include Amphastar Pharmaceuticals, Pfizer, ADAPT Pharma, Kaleo, Sandoz, Amneal Pharmaceuticals, West Ward Pharmaceuticals, Mylan, Angkor Data Communication Group Co., Ltd., Cybercomm, Route Mobile Limited, Infobip Ltd., Tyntec, Nexmo, DIMOCO and so on. The fierce competitiveness has made these players spend in product developments to improve the customer’s requirements.

Target Audience of the Naloxone Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

CHAPTER 1. GLOBAL NALOXONE MARKET DEFINITION & SCOPE

1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Data Mining
  2.1.2. Analysis
  2.1.3. Market Estimation
  2.1.4. Validation
  2.1.5. Publishing
2.2. Research Assumption

CHAPTER 3. EXECUTIVE SUMMARY

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends

CHAPTER 4. GLOBAL NALOXONE MARKET DYNAMICS

4.1. Growth Prospects
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunities
4.2. Industry Analysis
  4.2.1. Porter’s 5 Force Model
  4.2.2. PEST Analysis
  4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL NALOXONE MARKET BY PRODUCT

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Naloxone Market, Sub Segment Analysis
  5.3.1. Spray Forms
    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.2. Injectable Forms
    5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 6. GLOBAL NALOXONE MARKET BY APPLICATION

6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Naloxone Market, Sub Segment Analysis
  6.3.1. Opioid Overdose
    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.2. Preventing Opioid Abuse
    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.3. Others
    6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. GLOBAL NALOXONE MARKET, REGIONAL ANALYSIS

7.1. Naloxone Market, Regional Market Snapshot (2015-2025)
7.2. North America Naloxone Market Snapshot
  7.2.1. U.S.
    7.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.2.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.2.2. Canada
    7.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.2.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3. Europe Naloxone Market Snapshot
  7.3.1. U.K.
    7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.2. Germany
    7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.3. France
    7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.4. Rest of Europe
    7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.4. Asia Naloxone Market Snapshot
  7.4.1. China Naloxone Market Size Estimates & Forecasts, 2015-2025 (USD Billion)
    7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.4.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.4.2. India
    7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.4.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.4.3. Japan
    7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.4.3.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.4.4. Rest of Asia Pacific
    7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.4.4.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.5. Latin America Naloxone Market Snapshot
  7.5.1. Brazil
    7.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.5.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.5.2. Mexico
    7.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.5.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.6. Rest of The World
  7.6.1. South America
    7.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.6.1.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.6.2. Middle East and Africa
    7.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.6.2.2. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
    7.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 8. COMPETITIVE INTELLIGENCE

8.1. Company Market Share (Subject to Data Availability)
8.2. Top Market Strategies
8.3. Company Profiles
  8.3.1. Amphastar Pharmaceuticals
    8.3.1.1. Overview
    8.3.1.2. Financial (Subject to Data Availability)
    8.3.1.3. Product Summary
  8.3.2. Pfizer
  8.3.3. ADAPT Pharma
  8.3.4. Kaleo
  8.3.5. Sandoz
  8.3.6. Amneal Pharmaceuticals
  8.3.7. West Ward Pharmaceuticals
  8.3.8. Mylan
  8.3.9. Angkor Data Communication Group Co., Ltd.
  8.3.10. Cybercomm
  8.3.11. Route Mobile Limited
  8.3.12. Infobip Ltd.
  8.3.13. Tyntec
  8.3.14. Nexmo
  8.3.15. DIMOCO